No Results
"We are currently gathering more data to assess the safety of musculardystrophyuk.org. Your safety is our priority, and we're conducting a thorough analysis before providing a comprehensive evaluation."
Muscular Dystrophy UK is the UK's leading charity bringing together more than 60 rare and very rare progressive muscle-weakening and wasting conditions,
Traffic rank of musculardystrophyuk.org, compared to all other sites
↑ 865K+
United Kingdom
Website ranking is crucial for evaluating musculardystrophyuk.org's stats. TopWeb.ai leverages cutting-edge techniques, including data gathering, collection, and analysis from diverse internet resources, to estimate website traffic. Our assessments are based solely on publicly available information, offering valuable insights into potential traffic trends without relying on business owner-provided data. Additionally, we utilize advanced tools like ChatGPT and Gemini API to enhance our evaluation process, ensuring accurate and comprehensive traffic estimations and analysis.
Over the last three months, musculardystrophyuk.org's global ranking has increased from 2,443,796 to 1,578,561.
Total Visits
Bounce Rate
Pages per Visit
Avg Visit Duration
Moz metrics are by Moz that predicts how well a specific page will rank.
WOT's security score derives from our partners and community-driven expert reviews
Amazon Alexa Rank provides a broad gauge of a website's online popularity.
The Organic Search section reveals valuable insights, including organic traffic and keywords for in Google's top 100 search results.
Explore alternative, competitive and similar websites to musculardystrophyuk.org based on traffic, content and site structure.
CureDuchenne is the global leader in research, patient care and innovation for improving & extending the lives of children with Duchenne muscular dystrophy.
Cureduchenne alternatives
Duchenneuk alternatives
MDA is the nonprofit health agency dedicated to curing muscular dystrophy, ALS and related diseases by funding worldwide research.
Mda alternatives
Muscle alternatives
Musculardystrophynews alternatives
Parent Project Muscular Dystrophy (PPMD) fights to end Duchenne muscular dystrophy. We accelerate research, raise our voices to impact policy, demand optimal care for every single family, and strive to ensure access to approved therapies.
Parentprojectmd alternatives
Sarepta is at the forefront of precision genetic medicine, having built an impressive and competitive position in Duchenne muscular dystrophy (DMD) and more recently in gene therapies for 5 Limb-girdle muscular dystrophy diseases (LGMD), Charcot-Marie-Tooth (CMT), MPS IIIA, Pompe and other CNS-related disorders, totaling over 20 therapies in various stages of development. The Company’s programs and research focus span several therapeutic modalities, including RNA, gene therapy and gene editing. Sarepta is fueled by an audacious but important mission: to profoundly improve and extend the lives of patients with rare genetic-based diseases.
Sarepta alternatives
Head-first alternatives
Cancer alternatives
Check out some of our popular sites.